The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems

Community Mental Health Journal

Volumn 49, Issue 5, 2013, Pages 507-514

  Garland, Ann F ^a,b   Brookman Frazee, Lauren ^a,b   Gray, Emily ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Disruptive behavior; Medication treatment; Parent factors; Routine care

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; FAMILY SIZE; FEMALE; HUMAN; MALE; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PARENT; PRESCHOOL CHILD; SOCIOECONOMICS; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; COMMUNITY MENTAL HEALTH SERVICES; FAMILY CHARACTERISTICS; FEMALE; HUMANS; MALE; PARENTS; PSYCHOTROPIC DRUGS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84884534637     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10597-012-9514-1     Document Type: Article

References (40)

1. Andersen, R. M.; McCutcheon, A.; Aday, L. A.; Chiu, G. Y.; & Bell, R. (1983). Exploring dimensions of access to medical care. Health Services Research, 18, 49-74.
2. Angold, A.; Erkanli, E.; Farmer, E. M.; Fairbank, J. A.; Burns, B. J.; Keeler, G.; et al. (2002). Psychiatric disorder, impairment, and service use in rural African American and white youth. Archives of General Psychiatry, 59, 893-901.
3. Bickman, L.; Guthrie, P. R.; Foster, E. M.; Lambert, E. W.; Summerfelt, W. T.; Breda, C. S.; et al. (1995). Evaluating managed mental health services: The Fort Bragg experiment. New York: Plenum Press.
4. Biederman, J.; Spencer, T. J.; Newcorn, J. H.; Gao, H.; Milton, D. R.; Feldman, P. D.; et al. (2007). Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: A meta-analysis of controlled clinical trial data. Psychopharmacology (Berl), 190(1), 31-41.
5. Boggs, S. R.; Eyberg, S.; & Reynolds, L. A. (1990). Concurrent validity of the Eyberg child behavior inventory. Journal of Clinical Child Psychology, 19, 75-78.
6. Brannan, A. M.; Heflinger, C. A.; & Bickman, L. (1997). The caregiver strain questionnaire: Measuring the impact on the family of living with a child with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 5(4), 212-222.
7. Burke, J.; Loeber, R.; & Birmaher, B. (2002). Oppositional defiant disorder and conduct disorder: A review of the past 10 years, Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 41(11), 1275-1293.
8. Bussing, R.; Mason, D. M.; Leon, C. E.; & Sinha, K. (2003). Agreement between CASA parent reports and provider records of children's ADHD services. The Journal of Behavioral Health Services & Research, 30(4), 462-469.
9. Comer, J. S.; Olfson, M.; & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. Journal of the American Academy of Child and Adolescent Psychiatry, 49(10), 1001-1010.
10. Crystal, S.; Olfson, M.; Huang, C.; Pincus, H.; & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs, 28(5), 770-781.
11. Derogatis, L. R.; & Melisaratos, N. (1983). The brief symptom inventory: An introductory report. Psychological Medicine, 13(3), 595-605.
12. dos Reis, S.; Zito, J.; Safer, D.; Gardner, J.; Puccia, K.; & Owens, P. J. (2005). Multiple psychotropic medication use for youths: A two-state comparison. Journal of Child and Adolescent Psychopharmacology, 15(1), 68-77.
13. Essock, S. M.; Covell, N. H.; Leckman-Westin, E.; Lieberman, J. A.; Sederer, L. I.; Kealey, E.; et al. (2009). Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in New York State. Psychiatric Services, 60(12), 1595-1602.
14. Eyberg, S. M.; Nelson, M. M.; & Boggs, S. R. (2008). Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. Journal of Clinical Child & Adolescent Psychology, 37(1), 215-237.
15. Foster, E. M.; Kelsch, C. C.; Kamradt, B.; Sosna, T.; & Yang, Z. (2001). Expenditures and sustainability in systems of care. Journal of Emotional and Behavioral Disorders, 9, 53-70.
16. Garland, A. F.; Brookman-Frazee, L.; Hurlburt, M. S.; Accurso, E. C.; Zoffness, R. J.; Haine-Schlagel, R.; et al. (2010). Mental health care for children with disruptive behavior problems: A view inside the therapists' offices. Psychiatric Services, 61(8), 788-795.
17. Garland, A. F.; Hough, R. L.; McCabe, K. M.; Yeh, M.; Wood, P. A.; & Aarons, G. A. (2001). Prevalence of psychiatric disorders in youths across five sectors of care. Journal of the American Academy of Child and Adolescent Psychiatry, 40(4), 409-418.
18. Goodwin, R.; Gould, M.; Blanco, C.; & Olfson, M. (2001). Prescription of psychotropic medications to youths in office-based practice. Psychiatric Services, 52(8), 1081-1087.
19. Ipser, J.; & Stein, D. (2007). Systemic review of pharmacotherapy of disruptive behavior disorders in children and adolescents. Psychopharmacology (Berl), 19, 127-140.
20. Jensen, P. S.; Arnold, L. E.; Swanson, J. M.; Vitiello, B.; Abikoff, H. B.; Greenhill, L. L.; et al. (2007). 3 Year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 989-1002.
21. Jensen, P.; Bhatara, V.; Vitiello, B.; Hoagwood, K.; Feil, M.; & Burke, L. (1999). Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5), 557-565.
22. Kaplan, S.; Heiligenstein, J.; West, S.; Busner, J.; Harder, D.; Dittman, R.; et al. (2004). Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder. Journal of Attention Disorders, 8(2), 45-52.
23. Leslie, L. K.; Aarons, G. A.; Haine, R. A.; & Hough, R. L. (2007). Caregiver depression and medication use by youths with ADHD who receive services in the public sector. Psychiatric Services, 58(1), 131-134.
24. Leslie, L. K.; Weckerly, J.; Landsverk, J.; Hough, R. L.; Hurlburt, M. S.; & Wood, P. A. (2003). Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1433-1442.
25. Luby, J.; Stalets, M.; & Belden, A. (2007). Psychotropic prescriptions in a sample including both healthy and mood and disruptive disordered preschoolers: Relationships to diagnosis, impairment, prescriber type, and assessment methods. Journal of Child and Adolescent Psychopharmacology, 17(2), 205-215.
26. Marrato, E. H.; Nicol, G. E.; Maahs, D.; Druss, B. G.; Hartung, D. M.; Valuck, R. J.; et al. (2010). Metabolic screening in children receiving antipsychotic drug treatment. Pediatrics & Adolescent Medicine, 164(4), 344-351.
27. McCabe, K. M.; Yeh, M.; Lau, A.; Garland, A.; & Hough, R. (2003). Racial/ethnic differences in caregiver strain and perceived social support among parents of youth with emotional and behavioral problems. Mental Health Services Research, 5(3), 137-147.
28. McLennan, J.; Wathen, N.; MacMillan, H.; & Lavis, J. (2006). Research-practice gaps in child mental health. Journal of the American Academy of Child and Adolescent Psychiatry, 45(6), 658-665.
29. MTA group. (1999). A 14 month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Archives of General Psychiatry, 56(12), 1073-1086.
30. Olfson, M.; Marcus, S.; Weissman, M.; & Jensen, P. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 14(5), 514-521.
31. Pappadopulos, E.; et al. (2009). Medication adherence in MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitent behavioral therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 501-510.
32. Raghavan, R.; Zima, B. T.; Andersen, R. M.; Leibowitz, A. A.; Schuster, M. A.; & Landsverk, J. (2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15(1), 97-106.
33. Riddle, M.; Kastelic, E. A.; & Frosch, E. (2005). Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry and Allied Disciplines, 42(1), 73-90.
34. Shin, S.; & Brown, T. (2005). Racial and ethnic disparities in caregiver strain and the use of child mental health services: A structural equation model. Psychiatric Services, 60(8), 1039-1045.
35. van de Wiel, N. M.; Matthys, W.; Cohen-Kettenis, P. T.; Maassen, G. H.; Lochman, J. E.; & van Engeland, H. (2007). The effectiveness of an experimental treatment when compared to care as usual depends on the type of care as usual. Behavior Modification, 31(3), 298-312.
36. Varley, C.; & McClellan, J. (2009). Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents. Journal of American Medical Association, 302(16), 1811-1812.
37. Yeh, M.; McCabe, K.; Hough, R. L.; Lau, A.; Fakhry, F.; & Garland, A. (2005). Why bother with beliefs? Examining relationships between race/ethnicity, parental beliefs about causes of child problems and mental health service use. Journal of Consulting and Clinical Psychololgy, 73(5), 800-807.
38. Zima, B.; Hurlburt, M.; Knapp, P.; Ladd, H.; Tang, L.; Duan, N.; et al. (2005). Quality of publicly-funded outpatient specialty mental health care for common childhood psychiatric disorders in California. Journal of the American Academy of Child and Adolescent Psychiatry, 44(2), 130-144.
39. Zito, J.; Safer, D.; dos dosReis S, S.; Gardner, J. F.; Gardner, J. F.; Magder, L.; et al. (2003). Psychotropic practice patterns for youth: a 10 year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17-25.
40. Zito, J.; Safer, D.; Sai, D.; Gardner, J. F.; Thomas, D.; Coombes, P.; et al. (2008). Psychotropic medication patterns among youth in foster care. Pediatrics, 121, 157-163.